
Fran Quintana Lab
@quintanalabhms
Our goal is to combine advanced tools with innovative experimental models to study neuroinflammatory disorders and cancer. Tweets by lab members
ID: 1346872158748696577
https://quintanalab.bwh.harvard.edu/ 06-01-2021 17:32:07
191 Tweet
2,2K Followers
605 Following

Congrats to Jessica Kenison-White and Niko Stevens for this excellent review on the therapeutic induction of antigen-specific immune tolerance out today Nature Rev Immunol! nature.com/articles/s4157…

Thanks for the kind words Joon-Hyuk Lee! bwhclinicalandresearchnews.org/2024/02/01/men…



Congrats to Michael Kilian for making the cover of Science Immunology! This exciting story on NK cell-mediated lysis of activated T cells via B7H6 proposes a potential checkpoint mechanism for cancer immunotherapies

Great paper identifying a mechanism of inflammation-induced neurodegeneration in MS! Check out the preview written by Hong-Gyun Lee doi.org/10.1016/j.molc…

Yearly lab race: complete! Quintana lab rats zoomed through the RACE Cancer Foundation 5K yesterday, with an unlikely winner taking the first place 🏆 Next up - lab olympics?


Host-gut microbiota crosstalk predicts neuroinflammation - A quick read News and Views by Fran Quintana Lab. nature.com/articles/s4156…


#NewNProt describing a #microfluidic-based platform to study #cellcellinteractions bit.ly/4eM1WG4 Fran Quintana Lab

Today we all dressed up as our favorite and most consistently dressed scientist: Hong-Gyun Lee Happy Hongloween! 🎃👻



Our study on the protective role of CLEC16A in astrocytes in MS is out today in Nature Neuroscience! Congrats to Atsushi and all collaborators! nature.com/articles/s4159…


New review on our all-time favorite molecule out today in Nature Reviews Drug Discovery by Carolina Manganeli Polonio!



Therapeutic B cell depletion identifies immunoregulatory networks preview Journal of Clinical Investigation Fran Quintana Lab Carolina Manganeli Polonio jci.org/articles/view/… article David Hafler Pierre-Paul Axisa jci.org/articles/view/…


